Real ‐world effectiveness and persistence of golimumab as second‐line anti‐TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO‐BEYOND, a 12‐month prospective observational study
Source: International Journal of Rheumatic Diseases - Category: Rheumatology Authors: Salvatore D'Angelo,
Enrico Tirri,
Angela Maria Giardino,
Tiziana De Rosa,
Marco Matucci‐Cerinic,
Lorenzo Dagna,
Leonardo Santo,
Francesco Ciccia,
Bruno Frediani,
Marcello Govoni,
Francesca Bobbio Pallavicini,
Rosa Daniela Grembiale,
Andrea Tags: LETTER TO THE EDITOR Source Type: research
More News: Arthritis | Italy Health | Psoriatic Arthritis | Rheumatoid Arthritis | Rheumatology | Study